| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |